Get started
UNITEDHEALTH GROUPUNITEDHEALTH GROUPUNITEDHEALTH GROUP

UNITEDHEALTH GROUP

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

4UNH trade ideas

UNH trade 4/1/20market outlook: -Vixcentral: contango, no overt flattening of curve from M1-3 for the past week -VIX bouncing between 22-24 the past week which may indicate slow steady growth of SPY -SPY on up-trend, not overextended based on 20EMA ============= UNH - united health grp Almost correlates to SPY - went down when SPY went down but did not recover as much as the SPY in the past few months On 1H chart, a) just broke out of a 2 week triangle b) just crossed a resistance c) Crossed resistance with a hammer d) Crossed resistance with high volume and a volume ramp e) prior to hammer, there was a series of 4 green candlesticks that almost looks like 3 white solders pattern
NYSE:UNHLong
by tims9101
UNH - United Healthcare Overpriced?United Healthcare is trading between the upper Bollinger bands and upper Keltner channel bands and it couldn't be at a better time. The topic of the affordable care act is now making headlines as Republican-led states and the Trump administration voice their case to the Supreme Courts today, claiming that the Affordable Care Act Mandate is unconstitutional. While the outcome of this case is still pending and may not have an impact on the stock, United Healthcare has been known to react whenever there is a potential change in how Americans receive healthcare. Today, President elect Joe Biden made a speech in favor of keeping and protecting the affordable care act. Let's see if any of these recent events surrounding the affordable care act have an effect on United Healthcare's stock over the next few days. Just looking at the charts, my opinion is that the stock is overpriced. The stock is trading higher relative to the exponential moving average on the chart. So, any news related to the Affordable Care Act supreme court case could encourage a sell off. REMEMBER: Reference to specific securities should not be construed as a recommendation to buy, sell or hold that security. Specific securities are mentioned for educational and informational purposes only. YouCanTrade is an online media publication service which provides investment educational content, ideas and demonstrations, and does not provide investment or trading advice, research or recommendations.
NYSE:UNHShort
by UnknownUnicorn6775423
SPHealth 2 Week Comparisons (Oct 7-20 2020)SPHealth - Growth Analysis & Comparison - Cindicator Poll Submission (October 7th - 20th 2020) I've been looking through my Cindicator questions, making forecasts and watching markets as new polls pop up. Here's a comparison chart for 5 major S&P health companies and my rankings forecast. (Descending order from most growth to least) United Health Group Inc (UNH) Abbott Labs (ABT) Johnson & Johnson (JNJ) Pfizer Inc. (PFE) Merck & Co. (MRK) This forecast will be explicitly graded by total growth % comparisons of opening prices on October 7th to closing prices on October 20th across the 5 aforementioned companies. As of right now before 10-9-20 daily market open, the percentage growth is as follows: UNH +1.9% PFE +1.87% JNJ +1.56% ABT +1.1% MRK +0.54% When looking at a specific metric within the already completed duration since I submitted my forecast, overall recent growth is: UNH +2.82% PFE +2.66% JNJ +2.24% MRK +2.22% ABT +1.62% 10-9-20 Forecast Adjustments: Now that I have seen the last 2 days play out, I'm starting to notice a couple things about my forecast and actual live value. I'm confident that United Health will still outperform, but this outlook could change if any major market sell off occurs before the 20th. Pfizer looks like it could be a strong runner up, and I may have flubbed my original forecast by ranking it 4th in growth. Johnson & Johnson is performing approximately as expected. Merck and Abbott Labs could be tricky to pinpoint exactly without some further research and analysis but, I'm guessing that Abbott may come in 4th place if everything settles after any quick rallies that should happen. If a light pump in Merck occurs over the 19th-20th, then there could be a small chance it outperforms Abbott for 4th but it feels like an unlikely scenario. After these deliberations, I've decided my forecast doesn't need much adjusting other than to swap the placement of Pfizer and Abbott. My updated forecast is as follows: United Health Group Inc (UNH) Pfizer Inc. (PFE) Johnson & Johnson (JNJ) Abbott Labs (ABT) Merck & Co. (MRK) One thing to note is that I believe TradingView is not calculating its percentage scale correctly, its placing the 0% Y axis at the close value of the first candle used to calculate growth. So this graph is really just more for me to check my own work by hand, as the percentages on the left will not accurately portray what is actually being graded by Cindicator. I'll check back in after the 20th to see how this turned out! Thanks for tuning in :) Disclaimer, I am not responsible for any losses incurred while attempting to use my data, I hope this can prove to be some sort of learning tool for some and give insight as to how I personally come up with my own numbers. Take into full consideration this could be a completely bad forecast. Cheers
NYSE:UNH
by Hambooger
UNHSystem T Performances: Annual Compound Profit 40%, Win Rate 55%, Risk/Reward Ratio 1:2, 20 Years of Backtesting Data, Over 100 Markets. * Click Like and Follow to Support My Work! --- Hi Traders, I'd like to introduce the System T, a computerized trading system that analyzed and backtested the 20 years history data of over 100 markets. This post is my sharing of how I think about systematic trading and the signals generated by the System T. (This is my opinion only, NOT the financial advice.) The System T is a comprehensive system which contains many components such as buy & sell signal generator, win & loss statistics, risk control & portfolio management to make sure trading is successful in the long run. Basically, for the system to open a trade and manage risk, it only needs a buy signal & a stop-loss signal clearly on the chart. Once the system finds a good trend, it will ride it as long as possible. The stop-loss will be adjusted accordingly to the new price movement. (*) Remember to follow this trade idea and follow my profile to get updates about the stop-loss adjustment and sell signal based on the latest price and market conditions daily. System T performances above will give you an idea of how it performs in the last 20 years. Notice that this result was achieved only if I strictly followed the rule: "Only and Always Buy & Sell based on the System Signals". Don't sell when there is no sell signal as we all want to follow the good trends til the end like everything in life does. \(^-^)/ Also, my system is extremely diversified through over 100 markets so that it only risks less than -1% of the total capital per trade. Thank you and good luck! --- DISCLAIMER: I am NOT a financial advisor, and nothing I say is meant to be a recommendation to buy or sell any financial instrument. My views are general in nature and I am not giving financial advice. You should not take my opinion as financial advice. This is my opinion only. Do your own due diligence, and take 100% responsibility for your financial decisions. Trading and investing are risky! Don't invest money you can't afford to lose, because many traders and investors lose money. There are no guarantees or certainties in trading. - Content is for education purposes only, not investment advice. - Trading involves a high degree of risk. - We’re not investment or trading advisers. - Nothing we say is a recommendation to buy or sell anything. - There are no guarantees or certainties in trading. - Many traders lose money. Don’t trade with money you can’t afford to lose.
NYSE:UNHLong
by System_T